
ABSTRACT Pseudomonas aeruginosa is a high‐risk nosocomial pathogen responsible for severe hospital‐acquired infections. Its persistence in hospital environments is supported by biofilm formation, extensive antimicrobial resistance, and the ability to colonize water systems and medical devices. Genomic technologies have enhanced the understanding of its complex transmission routes. A narrative review approach was used to synthesize evidence from 2015 to 2025. Searches across major databases identified studies focused on environmental persistence, biofilms, genomic surveillance, outbreak reports, and infection prevention and control (IPC) strategies. Data were grouped into thematic areas covering pathogen biology, environmental reservoirs, and control approaches. Water distribution systems, including sinks, drains, showers, and wastewater plumbing, emerged as important, setting‐dependent sources of P. aeruginosa transmission. Biofilm‐mediated survival allowed long‐term colonization, resistance‐gene exchange, and recolonization after disinfection. Comparative genomic tools, when combined with epidemiological evidence, supported environmental–patient links in several outbreaks, revealing multiple clones circulating simultaneously. Medical devices such as bronchoscopes and ventilators also served as additional reservoirs when reprocessing practices were inadequate. Outbreaks reported across continents highlighted recurring system‐level gaps: poor plumbing design, limited environmental monitoring, inconsistent hand hygiene, and insufficient antimicrobial stewardship. Successful interventions included targeted plumbing replacement, waterless patient care, enhanced reprocessing protocols, real‐time sequencing, and integrated IPC stewardship programs. Environmental reservoirs are critical drivers of P. aeruginosa transmission in hospitals. Genomic surveillance provides high‐resolution evidence to support transmission hypotheses and timely interventions. Sustainable control requires robust environmental hygiene, engineering improvements, ongoing surveillance, rapid diagnostics, and stewardship, which is particularly vital in low‐resource settings.
ABSTRACT Metabolism of 1,2‐propanediol (1,2‐PD) in Salmonella enterica occurs via the activity of microcompartment (MCP) proteins encoded by the pdu gene system. In this report, we observed that Salmonella Typhimurium appears to display greater 1,2‐PD metabolism compared to S . Arizonae and S . Enteritidis. We were interested in whether species/strain differences in 1,2‐PD metabolism are also seen in respective pdu clones, as this could have implications for downstream studies and applications with these systems. We therefore cloned the 38‐kb pdu/cob/cbi regions from S . Arizonae, S . Enteritidis, and other S . Typhimurium strains as part of a first‐of‐kind comprehensive comparison. Remarkably, we found no differences in expression of the various cloned pdu systems. However, we observed that the S . Arizonae and S . Enteritidis clones appear to display a greater dependence on the Crp regulator as compared to the S . Typhimurium clone, and this dependence could be alleviated by overexpressing the PocR regulator. We found that lack of functional expression in Pseudomonas putida could be alleviated via PocR overexpression, demonstrating that the roadblock is at the transcriptional level. In Pectobacterium carotovorum , substitution of the native pdu promoter with a strong heterologous promoter allowed expression. A reporter assay system showed that S . Typhimurium PocR displayed higher transcriptional activation compared to S . Arizonae and S . Enteritidis PocR. Overall, this work demonstrates the central importance of the PocR regulator/transcriptional level of pdu expression and provides strategies to overcome pdu expression issues in other bacterial hosts.
Biofilm formation is a key determinant of persistence and pathogenicity in fungal infections, yet the genetic basis underlying its variability among clinical isolates remains poorly understood. In this study, a collection of 95 N. glabratus clinical isolates was analyzed in terms of biofilm formation capacity, revealing large phenotypic diversity. Interestingly, urinary tract associated isolates were found to produce, on average, twice as much biofilm as the remaining isolates. A more in-depth analysis was carried out focusing on a selection of three of the lowest biofilm producing and four of the highest biofilm producing isolates. Higher total biofilm mass was found to consistently correlate with higher metabolic activity and carbohydrate extracellular matrix content, while no correlation with virulence against the Galleria mellonella infection model could be detected. Whole-genome sequencing of these high and low biofilm producing strains led to a list of 184 genes whose mutation may underlie biofilm formation variability. Deletion of 24 of these genes, identified BST1, EST3, LSM7, AMS1 and ZCF21 as previously uncharacterized contributors to biofilm formation, whose disruption results in a measurable reduction in biofilm biomass. Altogether, the obtained knowledge suggests within-host positive selection in the urinary tract, for N. glabratus specialization towards biofilm growth. The identification of new effectors of biofilm formation is consistent with the existence of a multi-layered network that connects transcriptional regulation and cell surface architecture in biofilm development.
Early-life gut microbiota plays a critical role in livestock health and productivity. Probiotic interventions, particularly those employing bacteriocin-producing lactic acid bacteria (LAB), may contribute to modulation of microbial development during this critical period. This study evaluated Lactiplantibacillus pentosus AA86 (formerly Lactobacillus pentosus) and Pediococcus pentosaceus AA94 for genomic safety, bacteriocin potential, and their effects on calf gut microbiota. Whole-genome sequencing assessed antimicrobial resistance genes, virulence determinants, plasmid-associated elements, and bacteriocin-encoding genes. Both strains lacked detectable antimicrobial resistance genes, virulence determinants, and plasmid-related elements, while harboring pediocin-encoding genes consistent with potential antimicrobial functionality. In a 30-day feeding trial, eight calves (50 +/- 10 kg) were assigned to a control group (sterile skimmed milk, n = 2) or a probiotic group (milk supplemented with both strains at similar to 8.6 & times; 10(10) CFU/day, n = 6). Gut microbiota was evaluated at baseline, mid-, and post-intervention using 16S rRNA gene (V3/V4) sequencing and QIIME2. Alpha diversity and overall community structure did not differ significantly between groups. However, supplementation was associated with selective temporal compositional shifts, particularly in Firmicutes and Bacteroidetes. At the genus level, Lactobacillus showed significant temporal changes within treatment group, although the treatment-by-time interaction was not significant. L. pentosus AA86 and P. pentosaceus AA94 exhibited favorable genomic safety profiles and bacteriocin-associated antimicrobial potential. Their supplementation was associated with selective temporal modulation of the developing calf gut microbiota without substantial alteration of overall community structure. These findings provide a foundation for larger and longer-term studies incorporating strain-resolved, functional, metabolomic, and host health analyses.
The rise of antimicrobial resistance has increased interest in safe alternative therapeutic agents, including postbiotic mediators (PMs), which are sterile, cell-free, filter-sterilized preparations derived from probiotics. This study investigated the antifungal and antibiofilm activity of PMs derived from Lactobacillus rhamnosus GG (LGG) and Lactobacillus reuteri (LR) against Candida albicans, an opportunistic pathogen implicated in oral infections. PMs were prepared from LGG and LR cultures. The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) against C. albicans were determined using broth microdilution and colony-forming unit (CFU) counts. Antibiofilm activity at sub-MIC concentrations was evaluated by assessing metabolic activity (XTT assay) and biofilm architecture (scanning electron microscopy, SEM). The MIC and MFC of PMs from both LGG and LR were 25% (v/v). Both PMs significantly reduced the metabolic activity of C. albicans biofilms as measured by the XTT assay (p <= 0.002); however, a statistically significant reduction in viable biofilm counts was observed only with LGG PMs (p = 0.0038), whereas LR PMs showed a non-significant reduction (p = 0.1537). SEM showed marked changes in biofilm architecture. PMs from LGG and LR showed in vitro antifungal activity against C. albicans, with both preparations suppressing biofilm metabolic activity and LGG PMs additionally producing a statistically significant reduction in viable biofilm counts. These findings support further investigation of Lactobacillus-derived PMs as candidate adjunctive antifungal approaches; however, validation in clinical and antifungal-resistant isolates, chemical and mechanistic characterization, cytotoxicity testing, and in vivo studies are required before clinical application.